Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Pharmaceuticals and diagnostics technology producer Roche spun off Nimble Therapeutics, a US-based developer of chemical-synthesis drug discovery and development technology, on Tuesday with an amount of series A funding reported by Fierce Biotech to be $10m. Healthcare investment firm Telegraph Hill Partners led the round, which was closed as Nimble prepares to forge partnerships with other pharmaceutical companies.
Hangzhou Fansheng Technology, the China-based operator of insurance services platform Duobaoyu Insurance, has raised about $10m in series A-plus funding from investors…
